🗞 Newsmakers — 10AM ET, 2026-06-10

🔥 HOT SECTORS TODAY (the sectors to watch): Basic Materials +1.46% Financial Services +0.32% Healthcare +0.16% Real Estate -0.14%

📰 MARKET THEMES & CATALYSTS: • CPI Hits Multi-Year High as Inflation Lingers Over U.S. Consumers Even though CPI headline numbers hit in-line, the report is still a three-year high as the U.S.-Iran War continues to keep crude oil prices elevated. Kevin Hincks and Alex Coffey break down the report and explain how they see it impacting price action on Wall Street. — youtube.com · 06/10 9:30a https://www.youtube.com/watch?v=rd_y_g1Adtw • Nasdaq 100, Dow Jones 30 and S&P 500 Forecasts – US Indices Drop in Early Trading The US indices continue to look a bit rattled, as we are seeing a bit of selling pressure early in pre-market trading. At this point, I am looking to see if we get some kind of opportunity here for value. — fxempire.com · 06/10 9:22a https://www.fxempire.com/forecasts/article/nasdaq-100-dow-jones-30-and-sp-500-forecasts-us-indices-drop-in-early-trading-1603649 • Coda Octopus: The Market May Be Missing Its Underwater Defense Catalyst Coda Octopus Group is rated a cautious Buy at $11.80, driven by profitable operations and a robust balance sheet. CODA's upside hinges on scaling its IP-protected Marine Technology segment, especially Echoscope and DAVD, into larger defense programs. Recent Q1 FY2026 results sho… — seekingalpha.com · 06/10 9:10a https://seekingalpha.com/article/4913704-coda-octopus-the-market-may-be-missing-its-underwater-defense-catalyst • Nasdaq and Dow Jones futures cut losses after CPI inflation print US stocks were set to open lower on Wednesday, but investors gained a little confidence from fresh inflation data ahead of the opening bell, while there were conflicting Middle East messages that pushed oil prices higher. Futures pointed to a weaker start on Wall Street, with th… — proactiveinvestors.com · 06/10 9:05a https://www.proactiveinvestors.com/companies/news/1093718 • Nasdaq Quant Leaders: 5 Top Stocks Averaging 272% Forward EPS Growth AI-fueled earnings growth helped drive Nasdaq to record highs in 2026, despite valuation concerns, macro headwinds, and geopolitical tensions. Nasdaq-100 earnings grew 46% YoY in Q1, led by AI hyperscalers, but contributions broadened beyond big tech. Earnings remain the ultimat… — seekingalpha.com · 06/10 9:00a https://seekingalpha.com/article/4913519-nasdaq-quant-leaders-5-top-stocks-averaging-272-percent-forward-eps-growth

🐘 BIG-CAP MOVERS ON NEWS (≥$10B — the MRVL-class catalysts):

1. HOOD +8% $90.76 (82B cap) 3 Fintech Stocks Face Takeover Pressure as Consolidation Wave Builds Fintech consolidation is heating up as scaled payments, banking, and brokerage players hunt for vertical specialists with profitable unit economics. The 2026 backdrop favors deals: large incumbents have stronger balance sheets, artificial intelligence (AI) integration is forcing… — 247wallst.com · 06/10 9:10a https://247wallst.com/investing/2026/06/10/3-fintech-stocks-face-takeover-pressure-as-consolidation-wave-builds/

📈 TOP 7 GAINERS (small/mid-cap % leaders, with catalyst):

1. CBRL +33% $48.10 (1.1B cap) Remember Cracker Barrel's Logo Drama? That's in the Past After Solid Earnings. Cracker Barrel reports an unexpected profit in its fiscal third quarter. — barrons.com · 06/10 8:09a https://www.barrons.com/articles/cracker-barrel-earnings-stock-price-97ed138b

2. QH +26% $4.30 (389M cap) (no fresh news today — likely technical / low-coverage move)

3. RXT +24% $5.79 (1.4B cap) (no fresh news today — likely technical / low-coverage move)

4. CASY +14% $871.35 (32B cap) Casey's General Stores Q4: Hard To Buy At 41x Earnings Casey's General Stores, Inc. delivered an exceptional Q4 and FY2026, with Inside same store sales up 5.5% and EBITDA growth of 33%. CASY's strong business model, high margins, and expansion plans support its status as a compounder with durable moats and recession resilience. Des… — seekingalpha.com · 06/10 9:00a https://seekingalpha.com/article/4913705-caseys-general-stores-q4-hard-to-buy-at-41x-earnings

5. CLLS +14% $3.40 (341M cap) Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and… — globenewswire.com · 06/09 4:30p https://www.globenewswire.com/news-release/2026/06/09/3309345/0/en/Cellectis-Receives-FDA-RMAT-Designation-for-lasme-cel-the-First-Allogeneic-CAR-T-Therapy-in-a-Pivotal-Trial-for-Patients-with-r-r-B-ALL.html

6. HYLN +13% $7.19 (1.3B cap) (no fresh news today — likely technical / low-coverage move)

7. CLOV +13% $4.86 (2.5B cap) (no fresh news today — likely technical / low-coverage move)

— auto-generated, alert-only (not investment advice). 'No fresh news' = likely a technical/low-float move, not a catalyst.